Tag Archives: review

As a multi-agency pharmaceutical task force emerges now is the time for pharmaceutical companies to shape merger control policy

By Ross Mackenzie, Michelle A. Mantine and Isabelle Rahman on 4 June 2021 Posted in Antitrust Enforcement Agencies, Merger Control

Following a period of relative leniency for pharmaceutical companies, a Multilateral Pharmaceutical Merger Task Force formed by key antitrust enforcement agencies has been established to review and update merger analysis. The task force includes representatives from the Federal Trade Commission (FTC), the Canadian Competition Bureau, the European Commission Directorate General for Competition, the UK’s Competition … Continue Reading